FIRST TR EXCHANGE TRADED FD - NASDQ PHRMTCLS (FTXH)

Q2 2025 13F Holders as of 6/30/2025

Type / Class
Equity / NASDQ PHRMTCLS
Number of holders
18
Total 13F shares, excl. options
241K
Shares change
-5.77K
Total reported value, excl. options
$6.18M
Value change
-$192K
Number of buys
8
Number of sells
-9
Price
$25.63

Significant Holders of FIRST TR EXCHANGE TRADED FD - NASDQ PHRMTCLS (FTXH) as of Q2 2025

21 filings reported holding FTXH - FIRST TR EXCHANGE TRADED FD - NASDQ PHRMTCLS as of Q2 2025.
FIRST TR EXCHANGE TRADED FD - NASDQ PHRMTCLS (FTXH) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 241K shares .
Largest 10 shareholders include LPL Financial LLC (109K shares), GOLDMAN SACHS GROUP INC (32.2K shares), ENVESTNET ASSET MANAGEMENT INC (17.8K shares), Cambridge Investment Research Advisors, Inc. (17K shares), Ameritas Investment Partners, Inc. (15.7K shares), WMG Financial Advisors, LLC (10.8K shares), Vivaldi Capital Management LP (9.41K shares), BANK OF MONTREAL /CAN/ (8.22K shares), MORGAN STANLEY (5.92K shares), and UBS Group AG (4K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.